The acronym GLP-1 has become an increasingly popular term in the health arena, especially in the context of weight loss.

After selling off a portion of its diabetes care business last year, Ypsomed is now fully exiting the diabetes care business ...

A new GLP-1 drug, orforglipron, comes in pill form and appears to be roughly as effective as injected drugs like Ozempic.

A Monell Chemical Senses Center study published this week in the Journal of Clinical Investigation offers renewed hope for ...

Telehealth providers, whose revenue skyrocketed amidst GLP-1 shortages, remain defiant on their compounded semaglutide ...

Vivani Medical and Okava expand GLP-1 therapy research to dogs, aiming to advance long-acting treatments for cardiometabolic conditions.

Combination therapy with GLP-1 RAs and thiazolidinediones is associated with a reduced risk for mortality in patients with T2D, a study finds.

Supervised lifestyle intervention from a medical professional may help maximize fat loss and minimize muscle tissue loss in ...

A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

Medications like Ozempic and Zepbound work to mimic GLP-1, a hormone that makes you feel full. But there are also ways to ...

Employer health plans brace for ongoing soaring costs as weight-loss drug utilization rises. What trends are coming down the ...